GARDASIL 9 SUSPENSION INYECTABLE EN JERINGA PRECARGADA

Merck Sharp & Dohme B.V.🇪🇸 Spanish Agency of Medicines and Medical Devices

Approval Id: 9018a643d103174b
Drug Cima Aemps Name: GARDASIL 9 SUSPENSION INYECTABLE EN JERINGA PRECARGADA
Register Number: 151007002IP
Holder Company Name: Merck Sharp & Dohme B.V.
Marketing Company Name: Abacus Medicine A/S
Holder Company Detail Path: /organization/merck-sharp-and-dohme-bv
Authorization Date: 2022-09-22
Dosage Form: SUSPENSIÓN INYECTABLE EN JERINGA PRECARGADA
Dose: 0,5 ml
Route Of Administration: VÍA INTRAMUSCULAR
Prescription Type: Medicamento Sujeto A Prescripción Médica
Commercialized: No
Company Name: Merck Sharp & Dohme B.V.
Company Detail Path: /organization/merck-sharp-and-dohme-bv

VIRUS PAPILOMA HUMANO TIPO 16 PROTEINA L1

IP IP

VIRUS PAPILOMA HUMANO TIPO 6 PROTEINA L1

IP IP

VIRUS PAPILOMA HUMANO TIPO 18 PROTEINA L1

IP IP

VIRUS PAPILOMA HUMANO TIPO 11 PROTEINA L1

IP IP

VIRUS PAPILOMA HUMANO TIPO 31 PROTEINA L1

IP IP

VIRUS PAPILOMA HUMANO TIPO 33 PROTEINA L1

IP IP

VIRUS PAPILOMA HUMANO TIPO 45 PROTEINA L1

IP IP

VIRUS PAPILOMA HUMANO TIPO 52 PROTEINA L1

IP IP

VIRUS PAPILOMA HUMANO TIPO 58 PROTEINA L1

IP IP

Approved

Agency

CIMA-AEMPS

Country

🇪🇸

Approval Date

Sep 22, 2022

Approval ID

9018a643d103174b

Type

Standard